ResMed (RMD) GC Michael Rider Receives 3,230-Share Award

What Happened

• Michael J. Rider, Global General Counsel of ResMed Inc. (RMD), was granted/awarded 3,230 performance-based restricted stock units (RSUs) on August 14, 2026. The Form 4 reports the acquisition as 3,230 shares at $0.00 per share (total reported value $0), reflecting an award rather than a market purchase.

Key Details

• Transaction date: August 14, 2026; Form 4 filed: October 1, 2026 (appears late relative to the usual 2-business-day filing requirement).
• Reported transaction code: A (award/grant or other acquisition).
• Shares awarded: 3,230 RSUs; price reported: $0.00; total reported value: $0.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: These are performance-based RSUs granted on November 20, 2025. The RSUs were earned on August 14, 2026 when the compensation committee certified that the performance metrics were met. RSUs vest 1/3 each year on the anniversary of the grant.

Context

• This was an awarded compensation grant that became earned after performance certification — not a cash purchase or sale. Awards are routine components of executive pay and do not, by themselves, signal buying or selling intent in the open market.
• Vesting is time-based (1/3 per year on the grant anniversary), so the shares are subject to future vesting schedule and are not necessarily immediately tradable.